Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 774 of 1,261

  1. US 8927495

    Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  2. US 8927269

    Avian adenoassociated virus and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  3. US 8927573

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  4. US 8927275

    Differentiation of human embryonic and induced pluripotent stem cells

    UNIVERSITY OF CONNECTICUT · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  5. US 8926986

    Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  6. US 8927750

    Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules

    UNIVERSITAET REGENSBURG · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  7. US 8927233

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  8. US 8927215

    GNA11 mutations in melanoma

    The Regents of the University of California · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  9. US 8927030

    Use of nitrite salts for the treatment of cardiovascular conditions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  10. US 8927016

    Producing a sustained-release preparation

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  11. US 8926987

    Replication-competent adenoviral vectors

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  12. US 8926969

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  13. US 8927692

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  14. US 8927576

    HCV inhibitor and therapeutic agent combinations

    PTC THERAPEUTICS, INC. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  15. US 8927725

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  16. US 8926965

    Nucleic acid encoding superoxide dismutase variants and methods of use thereof

    The Regents of the University of California · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  17. US 8927564

    Synthesis of polycyclic alkaloids

    Rigel Pharmaceuticals, Inc. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  18. US 8926966

    Cloned glutamic acid decarboxylase

    The Regents of the University of California · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  19. US 8927557

    Methylpyrrolopyrimidinecarboxamides

    TAKEDA GMBH · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  20. US 8927709

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  21. US 8927730

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Northwestern University · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  22. US 8927528

    Composition for treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  23. US 8927249

    Extended soluble PH20 polypeptides and uses thereof

    HALOZYME, INC. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  24. US 8927718

    Fused heterocyclic ring derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.